Skip to content

Clinical trials

Completed Borderline Personality Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Borderline Personality Disorder Status: Completed Clear all

140 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20024
20032
200410
20053
20061
20071
20081
20094
20109
20116
20127
20135
20148
20158
20167
20175
20183
20198
20208
202114
20225
20237
20246
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed140

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health5
University of Minnesota5
Charite University, Berlin, Germany4
University Hospital, Montpellier4
Boehringer Ingelheim3
Ciusss de L'Est de l'Île de Montréal3
Evangelisches Krankenhaus Bielefeld gGmbH3
IRCCS Centro San Giovanni di Dio Fatebenefratelli3
Mclean Hospital3
New York State Psychiatric Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Borderline Personality Disorder140
Personality Disorders8
Stress Disorders, Post-Traumatic7
Anxiety Disorders4
Major Depressive Disorder4
Attention Deficit Disorder with Hyperactivity3
Bipolar Disorder3
Disruptive, Impulse Control, and Conduct Disorders2
Mental Disorders2
Parasomnias2

Trials

Showing 51 to 75 of 140. Each trial links to its page on Pharma Observatory.

40 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.